Table 1.
Demographic and clinical data of our population.
| PD | HC | ||
|---|---|---|---|
| Tot | 18 | 13 | |
| Sex (F/M) 1 | 08/10 | 06/07 | |
| Age (years) | 63.5 ± 8.1 | 62.8 ± 7.8 | |
| Dis. Duration (months) | Baseline | 35.7 ± 10 | |
| H&Y | Baseline | 2.05 ± 0.6 | |
| H&Y | Follow-up | 2.15 ± 0.5 | |
| MDS UPDRS-III | Baseline | 23.6 ± 6.2 | |
| MDS UPDRS-III | Follow-up | 24.3 ± 5.6 | |
| LEDD | Baseline | 450.3 ± 40.2 | |
| LEDD | Follow-up | 479.2 ± 25.4 | |
1 Abbreviations: M = male; F = female; H&Y = Hoehn & Yahr staging score; MDS UPDRS-III = Movement Disorders Society Unified Parkinson’s Disease Rating Sale Part III score; LEDD = Levodopa Equivalent Daily Dose.